What is Global Mouth-dissolving Tablets Market?
The Global Mouth-dissolving Tablets Market is a rapidly expanding sector within the pharmaceutical industry. These tablets, also known as orodispersible tablets, are designed to dissolve in the mouth, rather than being swallowed whole, making them an ideal solution for patients who have difficulty swallowing traditional tablets or capsules. The market encompasses a wide range of medications, including those used to treat conditions such as epilepsy, psychosis, and various gastrointestinal and cardiovascular diseases. The convenience and ease of use of these tablets have led to their increasing popularity, both among patients and healthcare providers. As a result, the market has seen significant growth in recent years, and this trend is expected to continue in the future.
Anti-Psychotics Drug, Anti-Epileptics Drug, Other in the Global Mouth-dissolving Tablets Market:
Anti-Psychotics Drug, Anti-Epileptics Drug, and Other drugs are some of the key segments of the Global Mouth-dissolving Tablets Market. Anti-psychotic drugs are used to manage conditions such as schizophrenia and bipolar disorder, while anti-epileptic drugs are used to treat epilepsy, a neurological disorder characterized by recurrent seizures. These drugs, when formulated as mouth-dissolving tablets, can provide patients with a more convenient and comfortable way to take their medication. Other drugs in this market include those used to treat a variety of conditions, from gastrointestinal disorders to cardiovascular diseases. The versatility of the mouth-dissolving tablet format means it can be used to deliver a wide range of medications, making it a valuable tool in the treatment of many different health conditions.
CNS Diseases, Gastrointestinal Diseases, CVS Diseases, Other in the Global Mouth-dissolving Tablets Market:
The Global Mouth-dissolving Tablets Market finds its application in a variety of areas including CNS Diseases, Gastrointestinal Diseases, CVS Diseases, among others. In the case of CNS diseases, these tablets offer a convenient mode of drug delivery for patients suffering from conditions like Parkinson's or Alzheimer's, where swallowing might be a challenge. For gastrointestinal diseases, these tablets can provide quick relief by dissolving instantly in the mouth. Similarly, in the case of CVS diseases, these tablets can be a lifesaver, providing immediate medication absorption in emergency situations. The versatility and convenience of mouth-dissolving tablets make them a preferred choice in many therapeutic areas.
Global Mouth-dissolving Tablets Market Outlook:
Looking at the market outlook for the Global Mouth-dissolving Tablets Market, it's clear that this sector is on a strong growth trajectory. In 2023, the market was valued at a substantial US$ 15320 million. However, this is expected to more than double by 2030, reaching an impressive US$ 33020 million. This represents a compound annual growth rate (CAGR) of 11.7% during the forecast period from 2024 to 2030. This robust growth can be attributed to the increasing demand for more convenient and patient-friendly drug delivery methods, as well as the ongoing development of new and improved mouth-dissolving tablet formulations.
| Report Metric | Details |
| Report Name | Mouth-dissolving Tablets Market |
| Accounted market size in 2023 | US$ 15320 million |
| Forecasted market size in 2030 | US$ 33020 million |
| CAGR | 11.7% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| Consumption by Region |
|
| By Company | Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb, Conquer |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
